Bristol Myers Squibb Co. (BMY)
67.23
+0.31
(+0.46%)
USD |
NYSE |
Sep 02, 12:42
Bristol Myers Squibb Net Income (Annual) : 7.056B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.056B |
| December 31, 2024 | -8.933B |
| December 31, 2023 | 8.04B |
| December 31, 2022 | 6.345B |
| December 31, 2021 | 7.014B |
| December 31, 2020 | -8.995B |
| December 31, 2019 | 3.46B |
| December 31, 2018 | 4.947B |
| December 31, 2017 | 975.00M |
| December 31, 2016 | 4.507B |
| December 31, 2015 | 1.631B |
| December 31, 2014 | 2.029B |
| December 31, 2013 | 2.58B |
| December 31, 2012 | 2.50B |
| December 31, 2011 | 5.252B |
| December 31, 2010 | 4.501B |
| December 31, 2009 | 4.402B |
| December 31, 2008 | 4.151B |
| December 31, 2007 | 2.731B |
| December 31, 2006 | 1.862B |
| December 31, 2005 | 3.584B |
| December 31, 2004 | 2.899B |
| December 31, 2003 | 3.47B |
| Date | Value |
|---|---|
| December 31, 2002 | 2.37B |
| December 31, 2001 | 2.145B |
| December 31, 2000 | 4.096B |
| December 31, 1999 | 4.167B |
| December 31, 1998 | 3.141B |
| December 31, 1997 | 3.205B |
| December 31, 1996 | 2.85B |
| December 31, 1995 | 1.812B |
| December 31, 1994 | 1.842B |
| December 31, 1993 | 1.959B |
| December 31, 1992 | 1.538B |
| December 31, 1991 | 2.056B |
| December 31, 1990 | 1.748B |
| December 31, 1989 | 747.00M |
| December 31, 1988 | 829.00M |
| December 31, 1987 | 709.60M |
| December 31, 1986 | 589.50M |
| December 31, 1985 | 531.40M |
| December 31, 1984 | 472.40M |
| December 31, 1983 | 408.00M |
| December 31, 1982 | 348.70M |
| December 31, 1981 | 305.80M |
| December 31, 1980 | 270.60M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Johnson & Johnson | 26.80B |
| Eli Lilly & Co. | 20.64B |
| Merck & Co., Inc. | 18.26B |
| Pfizer Inc. | 7.787B |
| AstraZeneca PLC | 10.26B |